Analyst Price Targets — BAX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 15, 2026 10:20 am | — | Goldman Sachs | $21.00 | $21.80 | TheFly | Baxter price target raised to $21 from $19 at Goldman Sachs |
| July 6, 2026 12:40 pm | Vijay Kumar | Evercore ISI | $24.00 | $22.22 | TheFly | Baxter price target raised to $24 from $22 at Evercore ISI |
| May 4, 2026 9:13 am | — | Barclays | $27.00 | $17.21 | TheFly | Baxter price target raised to $27 from $25 at Barclays |
| February 17, 2026 3:01 pm | — | Goldman Sachs | $17.00 | $20.54 | TheFly | Baxter price target lowered to $17 from $21 at Goldman Sachs |
| February 16, 2026 12:51 pm | Danielle Antalffy | UBS | $19.00 | $19.79 | TheFly | Baxter price target lowered to $19 from $21 at UBS |
| February 13, 2026 1:36 pm | — | Deutsche Bank | $20.00 | $19.23 | TheFly | Baxter price target lowered to $20 from $22 at Deutsche Bank |
| February 13, 2026 11:08 am | — | Barclays | $25.00 | $18.71 | TheFly | Baxter price target lowered to $25 from $30 at Barclays |
| February 12, 2026 8:55 pm | — | Jefferies | $19.00 | $18.71 | TheFly | Baxter price target lowered to $19 from $21 at Jefferies |
| February 12, 2026 8:43 pm | — | Stifel Nicolaus | $20.00 | $18.71 | TheFly | Baxter price target lowered to $20 from $22 at Stifel |
| January 9, 2026 12:19 pm | Matt Miksic | Barclays | $30.00 | $20.69 | TheFly | Baxter price target lowered to $30 from $36 at Barclays |
Latest News for BAX
Both AbbVie (NYSE:ABBV | ABBV Price Prediction) and Baxter International (NYSE:BAX) flashed the same technical signal this month: a golden cross, where the 50-day moving average pushed above the 200-day.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its second-quarter 2026 financial results on Thursday, July 30, 2026, at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/attendee/167756971 to pre-register for the call and receive the call information. This…
Baxter International Inc. (NYSE: BAX), a global medtech leader, today published its newly renamed [url="]2025 Sustainability Report[/url], highlighting the comp
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its newly renamed 2025 Sustainability Report, highlighting the company's progress and refreshed approach to advancing a sustainable and responsible business model. “As we shape Baxter's next chapter, our focus remains clear: making a meaningful difference for patients, customers and communities while…
BAX gains as Synovis MCA signs a multi-year deal to commercialize MediThinQ's SHIYA 3D surgical visualization platform worldwide.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.